The Heparin Anti-Xa Therapeutic Range
- 1 January 2002
- Vol. 121 (1) , 303-304
- https://doi.org/10.1378/chest.121.1.303
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2001
- Grades of Recommendation for Antithrombotic AgentsChest, 2001
- Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assayBlood Coagulation & Fibrinolysis, 2000
- Heparin Monitoring: The Confusion ContinuesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Two Instruments to Determine Activated Partial Thromboplastin Time: Implications for Heparin MonitoringPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparinClinical and Laboratory Haematology, 1999
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 1998
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- Inability of the Activated Partial Thromboplastin Time to Predict Heparin LevelsArchives of internal medicine (1960), 1997